Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 12/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.79 |
| ▸ | TUBB | P07437 | 1/20 | 0.79 |
| ▸ | YES1 | P07947 | 1/20 | 0.79 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.79 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.79 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.79 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.79 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.79 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.79 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.79 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.79 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.79 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.79 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.79 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.79 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.79 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.79 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.73 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butin SCHEMBL29929348 | 1.00 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Butin SCHEMBL29929512 | 1.00 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Butin SCHEMBL68554 | 1.00 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Liquirtigenin SCHEMBL74552 | 0.88 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Liquirtigenin SCHEMBL29552383 | 0.88 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Liquirtigenin SCHEMBL26970367 | 0.88 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Liquirtigenin SCHEMBL30352791 | 0.88 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Liquirtigenin SCHEMBL1071066 | 0.88 | CYP19A1 (1.00) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| SCHEMBL15218643 | 0.88 | CYP19A1 (0.79) | CYP19A1TUBB4ATUBBYES1TUBA3C | |
| Liquirtigenin SCHEMBL4649862 | 0.87 | CYP19A1 (0.97) | CYP19A1TUBB4ATUBBYES1TUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11517603-B2 | Bone remodeling accelerator | HOKURIKU UNIVERSITY (JP) | 2022-12-06 | — | — | US | claimed |
| US-20200268818-A1 | BONE REMODELING ACCELERATOR | HOKURIKU UNIVERSITY (JP) | 2020-08-27 | — | — | US | claimed |
| EP-3685836-A1 | BONE REMODELING ACCELERATOR | Hokuriku University (JP) | 2020-07-29 | — | — | EP | claimed |
| US-20180216152-A1 | METHOD FOR THE BIOTECHNOLOGICAL PRODUCTION OF FLAVONE GLYCOSIDE DIHYDROCHALCONES | SYMRISE AG (DE) | 2018-08-02 | — | — | US | claimed |
| US-9877946-B2 | Method for treating, managing, inhibiting, or preventing obesity | Research & Business Foundation Sungkyunkwan University (KR) | 2018-01-30 | — | — | US | claimed |
| EP-2963109-B1 | Process for the biotechnological production of flavanonglycoside dihydrochalcones | SYMRISE AG (DE) | 2017-09-06 | — | — | EP | claimed |
| US-20170087126-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVER SITY (KR) | 2017-03-30 | — | — | US | claimed |
| US-9549908-B2 | Composition for inducing differentiation into beige and brown adipocytes and method of inducing the same | Research & Business Foundation Sungkyunkwan University, Ltd. (KR) | 2017-01-24 | — | — | US | claimed |
| WO-2016050656-A1 | METHOD FOR THE BIOTECHNOLOGICAL PRODUCTION OF FLAVONOIDS | SYMRISE AG (DE) | 2016-04-07 | — | — | WO | claimed |
| EP-3002335-A1 | Process for the biotechnological production of flavonoids | Symrise AG (DE) | 2016-04-06 | — | — | EP | claimed |
| US-20150374643-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2015-12-31 | — | — | US | claimed |
| US-11517603-B2 | Bone remodeling accelerator | HOKURIKU UNIVERSITY (JP) | 2022-12-06 | — | — | US | disclosed |
| US-20200268818-A1 | BONE REMODELING ACCELERATOR | HOKURIKU UNIVERSITY (JP) | 2020-08-27 | — | — | US | disclosed |
| US-20200268818-A1 | BONE REMODELING ACCELERATOR | HOKURIKU UNIVERSITY (JP) | 2020-08-27 | — | — | US | disclosed |
| EP-3685836-A1 | BONE REMODELING ACCELERATOR | Hokuriku University (JP) | 2020-07-29 | — | — | EP | disclosed |
| WO-2006020164-A1 | SKIN CARE COMPOSITION CONTAINING A FLAVONOID AND VITAMIN B3 | THE PROCTER & GAMBLE COMPANY (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20060018861-A1 | Skin care composition | PROCTER & GAMBLE COMPANY, THE | 2006-01-26 | — | — | US | disclosed |
| US-20060018858-A1 | Skin care composition | THE PROCTER & GAMBLE COMPANY | 2006-01-26 | — | — | US | disclosed |
| US-20060018862-A1 | Substrate based skin care device | PROCTER & GAMBLE COMPANY, THE | 2006-01-26 | — | — | US | disclosed |
| US-20060018860-A1 | Skin care composition | PROCTER & GAMBLE COMPANY, THE | 2006-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170087126-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | FABP4, PLIN1, PRDM7 | CYP19A1 1244/4885TUBB4A 859/4885TUBB 2704/4885 |
| US-11517603-B2 | Bone remodeling accelerator | SOST, COL2A1, CXCL12 | CYP19A1 43/4885TUBB4A 4328/4885TUBB 4771/4885 |
| US-20200268818-A1 | BONE REMODELING ACCELERATOR | SOST, COL2A1, CXCL12 | CYP19A1 43/4885TUBB4A 4328/4885TUBB 4771/4885 |
| US-20150374643-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | FABP4, PLIN1, PRDM7 | CYP19A1 1244/4885TUBB4A 859/4885TUBB 2704/4885 |
| US-20060018860-A1 | Skin care composition | CUTA, C1QBP, FLNB | CYP19A1 1611/4885TUBB4A 464/4885TUBB 911/4885 |
| US-20060018862-A1 | Substrate based skin care device | CUTA, TYR, PROC | CYP19A1 357/4885TUBB4A 4224/4885TUBB 4121/4885 |
| US-20060018858-A1 | Skin care composition | CUTA, FLNB, CYP24A1 | CYP19A1 799/4885TUBB4A 359/4885TUBB 806/4885 |
| US-20060018861-A1 | Skin care composition | CUTA, SERPINB6, FLNB | CYP19A1 1092/4885TUBB4A 364/4885TUBB 705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.